Skip to main content
Clinical Trials/NCT01707615
NCT01707615CompletedPhase 2

Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Carotid Intima-media Thickness and Atherosclerotic Plaques in Clinical Use

Jie Qiu0 sites287 target enrollmentStarted: October 2006Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
287
Primary Endpoint
Carotid B-Mode Ultrasound

Study Overview

Brief Summary

The purpose of this study is to investigate the antiatherogenic effect of GSPE in clinical use

Detailed Description

Atherosclerotic plaques indicate the occurrence of ischemia events and how to deal with it is a difficult task for clinical physicians. Grape seed proanthocyanidin extrat (GSPE) has been reported to exert an antiatherogenic effect by inducing regression of atherosclerotic plaques in animal experimental studies. In this study, the antiatherogenic effect of GSPE has been investigated in clinical use.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
43 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • (1) carotid ultrasound examination: presence of carotid plaque or abnormal CIMT of between 0.9 and 1.2mm; (2) lipid profile: LDL≦3.12mmol/L, TC≦5.2mmol/L; (3) no lipid-lowering treatment within the past 6 months.

Exclusion Criteria

  • severe cardiomyopathy, acute coronary syndrome, hepatic dysfunction, end-stage renal failure (serum creatinine ≥117mmol/L), prior carotid endarterectomy, and/or patients who did not agree to participate in the present study.

Arms & Interventions

GSPE group

Active Comparator

GSPE 240 mg/day (120mg bid) in addition to the same lifestyle intervention.

Intervention: lifestyle intervention (Other)

control group

Other

In the control group, all patients were enrolled in a lifestyle intervention

Intervention: lifestyle intervention (Other)

GSPE group

Active Comparator

GSPE 240 mg/day (120mg bid) in addition to the same lifestyle intervention.

Intervention: GSPE (Drug)

Outcomes

Primary Outcomes

Carotid B-Mode Ultrasound

Time Frame: Carotid ultrasound examination was performed at baseline and 6, 12, 24months after treatment.The change of carotid plaque was record within 24 months.

The common, internal, and external carotid arteries were carefully identified by combining B-mode ultrasonography and color-Doppler duplex examination in the anterior oblique, lateral, and posterior oblique planes. All data was collected in 12 segments: the near (intimal-luminal surface) and far (medial- adventitial) walls of the distal common (1 cm proximal to dilation of the carotid bulb), the bifurcation (1cm proximal to the flow divider), and the proximal internal (1 cm section of the internal carotid artery immediately distal to the flow divider) left and right carotid artery.

Secondary Outcomes

  • clinical vascular events(after 24 months follow-up)

Investigators

Sponsor
Jie Qiu
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Jie Qiu

Qilu Hospital of Shandong University

Shandong University

Similar Trials